Tony Ho

Tony Ho

Company: CRISPR Therapeutics

Job title: Head of Research & Development

Seminars:

Chair’s Closing Remarks 5:15 pm

Read more

day: Day One

Panel Discussion: Exploring Gene Editing as a Means to Protect Transplanted Cells from a Patients’ Immune System 4:15 pm

• Learning how the advent of novel gene editing tools provides unique opportunities to disassemble MHC components in stem cell lines used to produce pancreatic-lineage cells to prevent presentation of alloantigens and autoantigens by the stem cell-derived beta cells and recognition by memory autoimmune cells in T1D patients • To what extent can eliminating MHC…Read more

day: Day One

Chair’s Opening Remarks 9:00 am

Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.